BERLIN (Reuters) -German pharma company Bayer reported positive study results for its anticoagulant asundexian on Sunday, two years after a research setback for the promising blood thinner candidate.
In a Phase III study, a daily dose of 50 milligrams significantly reduced the risk of ischemic stroke compared with a placebo, Bayer said.
Detailed results from the OCEANIC-STROKE study will be presented at an upcoming scientific congress, said Bayer.
Bayer added that it plans to speak with health authorities worldwide in preparation for the submission of marketing authorisation applications.
Bayer had originally predicted that asundexian would have peak sales potential of more than 5 billion euros ($5.76 billion) - more than any of its other drugs.
At the end of 2023, the company had a major setback with the drug after it failed in a pivotal clinical trial involving patients with atrial fibrillation and a risk of stroke.
($1 = 0.8687 euros)
(Reporting by Joern Poltz. Writing by Miranda Murray. Editing by Jane Merriman)
latest_posts
- 1
My Dad Can't Travel Like He Used to, but Slowing Down Doesn't Mean Stopping - 2German foreign minister heads to China to talk rare-earth exports
- 3Sanofi to acquire hepatitis B vaccine maker Dynavax for $2.2 billion
- 4Luigi Mangione‘s lawyers say Bondi’s death penalty decision was tainted by conflict of interest
- 57 Straightforward Moves toward Move Information from Your Old Cell phone to Your New One: A Thorough Aide
- Two separate Israeli espionage cases uncover Iran-linked activities in Jerusalem, Ashkelon
- Social Skylines d: A Survey of \Inside and out Social Experiences\ Language Learning Book
- US measles cases surpass 2,000, highest in 30 years: CDC
- JW Marriott Tokyo: an elegant retreat amid whirlwind of the city
- This country music star spent years hiding his sexuality. Coming out — and beating addiction — has made his soul feel '20 pounds lighter.'
- Step by step instructions to Boost the Eco-friendliness of Your Smash 1500.
- Before trips to Mars, we need better protection from cosmic rays
- High Court freezes government move to shutter Army Radio pending ruling
- The 10 Most Famous Works of art Ever
